Carcinoma, Hepatocellular: all 3,249 studies
Page 33 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00238394Phase 2
- Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCCCompletedNCT00234182Phase 1/2
- Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver ReserveTerminatedNCT00225290Phase 3
- Screening of Hepatocellular Carcinoma in Patients With Compensated CirrhosisCompletedNCT00190385Phase 3
- A National Registry of Patients With Hepatocellular CarcinomaCompletedNCT00178867
- Genetic Studies in Liver Cancer PatientsStatus unknownNCT00172640
- A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular CarcinomaTerminatedNCT00165633Phase 2/3
- Bevacizumab in Advanced Hepatocellular CarcinomaStatus unknownNCT00162669Phase 2
- Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular CarcinomaStatus unknownNCT00155272Phase 1/2
- Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular CarcinomaStatus unknownNCT00155103
- A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00154817Phase 2
- Searching for the Liver Cancer-Related BiomarkersStatus unknownNCT00154544
- Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDIStatus unknownNCT00154531
- Phase Ⅲ Randomized Trial in Postoperative Hepatocellular CarcinomaCompletedNCT00149565Phase 3
- Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaCompletedNCT00142467Phase 2
- Cetuximab in Patients With Unresectable or Metastatic Hepatocellular CarcinomaCompletedNCT00142428Phase 2
- Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)CompletedNCT00122876Phase 1/2
- Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin AloneStatus unknownNCT00121914Phase 3
- Trial for Hepatocellular Carcinoma Adjuvant Treatment by LipiocisCompletedNCT00116454Phase 3
- Adult-to-Adult Living Donor Liver Transplantation StudyCompletedNCT00096733
- A Trial of Thymalfasin in Adult Patients With Hepatocellular CarcinomaCompletedNCT00082082Phase 2
- A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical CareTerminatedNCT00081900Phase 1/2
- Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver CancerCompletedNCT00081094Not applicable
- Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver TransplantationCompletedNCT00080236Phase 2
- Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)Status unknownNCT00079027Phase 3
- Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077441Phase 2
- TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077142Phase 1/2
- Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular CarcinomaCompletedNCT00076609Phase 1/2
- Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00073736Phase 1/2
- Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00071994Phase 2
- Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNCT00057980Phase 1/2
- A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesStatus unknownNCT00057395Phase 1/2
- T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma PatientsTerminatedNCT00057382Phase 2/3
- Testing of ADI-PEG in Hepatocellular CarcinomaCompletedNCT00056992Phase 2
- Safety and Efficacy of Doxorubicin Adsorbed to Magnetic BeadsStatus unknownNCT00054951Phase 1/2
- Oxaliplatin in Treating Patients With Liver CancerCompletedNCT00052364Phase 2
- Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular CarcinomaTerminatedNCT00051545Phase 3
- Seocalcitol Versus Placebo in Advanced Hepatocellular CarcinomaTerminatedNCT00051532Not applicable
- Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver DysfunctionCompletedNCT00047346Phase 1
- Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically RemovedTerminatedNCT00047333Phase 2
- Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00047229Phase 2
- Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.Status unknownNCT00043433Phase 2
- Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver CancerTerminatedNCT00034333Phase 2/3
- Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder CancerCompletedNCT00033462Phase 2
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
- BMS-247550 in Treating Patients With Liver or Gallbladder CancerTerminatedNCT00023946Phase 2
- Treatment of Hepatocellular Carcinoma With TetrathiomolybdateCompletedNCT00006332Phase 2
- Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by SurgeryCompletedNCT00006016Phase 2